News

March 21, 2017

Genentech Roche Releases Community Letter with Clinical Trial Updates

Genentech Roche Releases Community Letter with Clinical Trial Updates

Genentech Roche provided the following community statement with clinical trial updates for SUNFISH (Type 2/3), FIREFISH (Type 1) and JEWELFISH. 

Dear SMA community,

At Genentech (A Member of the Roche Group) we are committed to addressing the urgent needs of...

READ MORE   |  

Topics: Clinical Trials, Front Page News

March 16, 2017

AveXis Reports Results from Phase 1 Trial of AVXS-101

AveXis Reports Results from Phase 1 Trial of AVXS-101

AveXis, Inc., a clinical-stage gene therapy company developing treatments for patients suffering from rare and life-threatening neurological genetic diseases, today reported

READ MORE   |  

Topics: Clinical Trials, Front Page News

January 13, 2017

Biogen Presents New ENDEAR Data Showing SPINRAZA (nusinersen) Significantly Reduces Risk of Death or Permanent Ventilation

Biogen presented new data from the Phase 3 ENDEAR study of SPINRAZA™ (nusinersen), which demonstrated a statistically significant reduction in the risk of death or permanent...

READ MORE   |  

Topics: Clinical Trials, Research, Front Page News

Items 1 - 3 of 89  12345678910Next

© 2014 Cure SMA | Privacy Policy

Powered by Blackbaud
nonprofit software